Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-4-22
|
pubmed:abstractText |
The p47phox-/- mouse exhibits a phenotype similar to that of human chronic granulomatous disease (CGD) and, thus, is an excellent model for the study of gene transfer technology. Using the Moloney murine leukemia virus-based retroviral vector MFG-S encoding the human form of p47phox, we performed ex vivo gene transfer into Sca-1+ p47phox-/- marrow progenitor cells without conditioning of donors with 5-fluorouracil. Transduced progenitors were transplanted into moderately irradiated (500 cGy), G-CSF preconditioned sibling p47phox-/- mice. Using the fluorescent probe dihydrorhodamine 123 (DHR), in vivo biochemical correction of the superoxide-generating NADPH oxidase system was detected by flow cytometry in 12.3% +/- 0.9% of phorbol myristate acetate-stimulated peripheral blood neutrophils at 4 weeks and 2.6% +/- 1.0% at 14 weeks after transplantation. Following gene therapy, mice were challenged with the CGD pathogen Burkholderia (formerly Pseudomonas) cepacia and bacteremia levels were assessed at 24 hours and 7 days after inoculation. At both time points, bacteremia levels in gene corrected p47phox-/- mice were significantly lower than untreated p47phox-/- mice (0.89 +/- 0.30 colonies v 237.7 +/- 83.6 colonies at 24 hours, P < .02; 4.0 +/- 2.0 colonies v 110.2 +/- 26.5 colonies at 7 days, P < .0014). More importantly, Kaplan-Meier survival analysis showed a significant survival advantage of gene corrected versus untreated p47phox-/- mice (P < .001). Thus, stem-cell-directed ex vivo gene therapy is capable of restoring phagocyte oxidant-dependent host-defense function in this mouse model of a human immune-system disorder.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2268-75
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9116268-Animals,
pubmed-meshheading:9116268-Bacteremia,
pubmed-meshheading:9116268-Bone Marrow Transplantation,
pubmed-meshheading:9116268-Burkholderia Infections,
pubmed-meshheading:9116268-DNA, Complementary,
pubmed-meshheading:9116268-Disease Susceptibility,
pubmed-meshheading:9116268-Gene Transfer Techniques,
pubmed-meshheading:9116268-Genetic Vectors,
pubmed-meshheading:9116268-Granulomatous Disease, Chronic,
pubmed-meshheading:9116268-Humans,
pubmed-meshheading:9116268-Mice,
pubmed-meshheading:9116268-Mice, Knockout,
pubmed-meshheading:9116268-Moloney murine leukemia virus,
pubmed-meshheading:9116268-NADPH Oxidase,
pubmed-meshheading:9116268-Phosphoproteins,
pubmed-meshheading:9116268-Radiation Chimera
|
pubmed:year |
1997
|
pubmed:articleTitle |
Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.
|
pubmed:affiliation |
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1886, USA.
|
pubmed:publicationType |
Journal Article
|